Genmab — Januar 2019
-
Nå den fik lidt i luk...kun n
ede 3,4% -
GENMAB A/S: GENMAB ANNOUNCES INITIATION OF U.S. FDA REGULATORY SUBMISSION FOR LABEL EXPANSION OF DARATUMUMAB IN COMBINATION WITH LENALIDOMIDE AND DEXA
16:57
Company Announcement- First part of regulatory package submitted to the U.S. FDA for label
expansion of daratumumab in combination with lenalidomide and
dexamethasone for patients with newly diagnosed multiple myeloma who
are not candidates for high dose chemotherapy and autologous stem
cell transplant - The U.S. FDA plan to review th
- First part of regulatory package submitted to the U.S. FDA for label
-
@ den fattige. Hvad står der til sidst?
-
underligt tidpunkt 16.57 ??
-
-
Helge er åbenbart lidt ligesom Twitter. Der er et maksimum anslag per indlæg
-
Sådan...FEDT!!
-
dejligt med en god nyhed - at long fucking last
-
Tak Den Fattige. Du er hermed kommet med på julekortlisten
-
Pyha. Det trængte vi også til
-
jeg måtte sgu selv slette min salgs ordre på 995 kr kl 16.59.xx
da den kom -
hmm, man plejer normalt at offentliggøre submission af ansøgningen - tyder på det er samme procedure for rtor
-
Det må blive bedre i morgen..;-D
-
Hvor lang tid går der i teorien før vi har en afgørelse fra FDA?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind